Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
NCT ID: NCT01339598
Last Updated: 2015-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
15 participants
INTERVENTIONAL
2011-09-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS(Transcranial Direct Current Stimulation) Efficacy in Bipolar Depression : RCT Study
NCT03974815
The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression
NCT03287037
Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
NCT01562184
Transcranial Direct Current Stimulation Therapy for Bipolar Depression
NCT05436613
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
NCT04296604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sham transcranial direct current stimulation
Transcranial direct current stimulation (Eldith DC Stimulator)
Eldith DC Stimulator (NeuroConn GmbH, Germany)
Transcranial direct current stimulation
Transcranial direct current stimulation (Eldith DC Stimulator)
Eldith DC Stimulator (NeuroConn GmbH, Germany)
Different transcranial direct current stimulation montage
Transcranial direct current stimulation (Eldith DC Stimulator)
Eldith DC Stimulator (NeuroConn GmbH, Germany)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial direct current stimulation (Eldith DC Stimulator)
Eldith DC Stimulator (NeuroConn GmbH, Germany)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A score of ≤ 20 on the MADRS, and a score of ≤ 6 on the YMRS, who have been on a stable dose of mood stabiliser medications for at least 1 month.
Exclusion Criteria
* Co-morbid DSM-IV diagnosis of any psychotic disorder (current or within the last year), schizophrenia and schizoaffective disorder
* Mental retardation
* A history of drug or alcohol abuse or dependence within the last 3 months
* Co-morbid attention deficit hyperactivity disorder (ADHD), or any neurological disorder
* Recent stroke
* Head injury
* History of seizure, or who have had electroconvulsive therapy (ECT) within the 6 months preceding enrolment.
* Participants will also be excluded if currently taking medications known to be associated with frank cognitive impairment (e.g., benzodiazepines).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of New South Wales
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of New South Wales
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of New South Wales
Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC 11065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.